CROMSOURCE Launches TalentSource Life Sciences Staffing Solutions Service
Verona, 9th June 2015: CROMSOURCE today announces the launch of TalentSource Life Sciences, a new name and brand identity for its established staffing solutions service for the clinical life sciences industry. The new brand name reflects TalentSource Life Sciences’ commitment to providing talented experts who make strong contributions within their roles at client companies. The logo selected for the brand combines an image of a figure with outstretched arms ready to assist, with a stylized double helix, reflective of the fact that clinical research is in the corporate DNA of TalentSource Life Sciences.
‘In our industry, the influence of generalist staffing agencies has grown over recent years,’ noted Sabine Hutchison, a respected industry executive who recently joined CROMSOURCE as a consultant to lead the TalentSource Life Sciences division. ‘In contrast, our customers tell us that they appreciate the expertise of the professionals we provide, the support that we give them, and the value of a partner that truly understands the business in which they operate.’
‘After over 20 years of success under the CROMSOURCE banner, we felt the time was right to create a new identity for our staffing solutions service,’ noted Oriana Zerbini, CEO of CROMSOURCE. ‘In doing so we wanted to emphasize our philosophy of flexibly providing the most highly trained, well supported experts in the business, who can call on the expertise of CROMSOURCE to support them and the work of our clients.’
About CROMSOURCE: Founded in 1994, CROMSOURCE is the leading independent provider of comprehensive international outsourced services to the pharmaceutical, biotechnology and medical device industries, specialized in clinical development and staffing solutions across Europe and North America.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Phase III Trial Data Show Subcutaneous Pembrolizumab as Noninferior to IV Keytruda
March 31st 2025Subcutaneous administration of pembrolizumab with chemotherapy demonstrated a nearly 50% reduction in patient chair and treatment room time while maintaining efficacy and safety endpoints compared to intravenous Keytruda.
Phase II ALPACA Trial Shows Lepodisiran Produces Significant, Sustained Lipoprotein(a) Reductions
March 31st 2025Eli Lilly’s lepodisiran, an investigational siRNA therapy, achieved significant and durable reductions in lipoprotein(a) levels, a major genetic risk factor for cardiovascular disease.
